======= TBX2 ======= == Gene Information == * **Official Symbol**: TBX2 * **Official Name**: T-box transcription factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6909|6909]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q13207|Q13207]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TBX2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBX2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600747|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Involved in the transcriptional regulation of genes required for mesoderm differentiation. Probably plays a role in limb pattern formation. Acts as a negative regulator of PML function in cellular senescence. May be required for cardiac atrioventricular canal formation. {ECO:0000269|PubMed:22002537}. |TBX| |T-box| |regulation of cardiac chamber morphogenesis| |negative regulation of cardiac chamber morphogenesis| |regulation of cardiac chamber formation| |negative regulation of cardiac chamber formation| |negative regulation of heart looping| |regulation of heart looping| |muscle cell fate determination| |mammary placode formation| |pharynx development| |mammary gland formation| |regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation| |atrioventricular canal development| |cardiac muscle cell myoblast differentiation| |ectodermal placode formation| |ectodermal placode morphogenesis| |ectodermal placode development| |cardioblast differentiation| |regulation of transcription from RNA polymerase II promoter involved in heart development| |muscle cell fate commitment| |negative regulation of morphogenesis of an epithelium| |positive regulation of cardiac muscle cell proliferation| |negative regulation of embryonic development| |embryonic camera-type eye morphogenesis| |outflow tract septum morphogenesis| |aorta morphogenesis| |cellular senescence| |positive regulation of cardiac muscle tissue growth| |negative regulation of animal organ morphogenesis| |embryonic eye morphogenesis| |myoblast differentiation| |endocardial cushion morphogenesis| |positive regulation of heart growth| |embryonic camera-type eye development| |cell fate determination| |regulation of heart morphogenesis| |regulation of cardiac muscle cell proliferation| |endocardial cushion development| |mammary gland morphogenesis| |positive regulation of cardiac muscle tissue development| |positive regulation of organ growth| |mesenchyme morphogenesis| |aorta development| |RNA polymerase II activating transcription factor binding| |regulation of cardiac muscle tissue growth| |heart looping| |artery morphogenesis| |embryonic digit morphogenesis| |cell aging| |regulation of heart growth| |embryonic heart tube morphogenesis| |determination of heart left/right asymmetry| |positive regulation of muscle organ development| |positive regulation of striated muscle tissue development| |positive regulation of muscle tissue development| |cardiac septum morphogenesis| |outflow tract morphogenesis| |embryonic heart tube development| |regulation of cardiac muscle tissue development| |artery development| |cell fate specification| |roof of mouth development| |regulation of organ growth| |gland morphogenesis| |cardiac septum development| |camera-type eye morphogenesis| |developmental growth involved in morphogenesis| |cardiocyte differentiation| |determination of left/right symmetry| |determination of bilateral symmetry| |specification of symmetry| |embryonic limb morphogenesis| |Notch signaling pathway| |embryonic appendage morphogenesis| |cardiac chamber morphogenesis| |mammary gland development| |regulation of embryonic development| |digestive tract development| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |digestive system development| |eye morphogenesis| |appendage morphogenesis| |limb morphogenesis| |stem cell differentiation| |cardiac muscle tissue development| |cardiac chamber development| |positive regulation of developmental growth| |appendage development| |regulation of morphogenesis of an epithelium| |limb development| |transcription factor complex| |mesenchyme development| |regulation of heart contraction| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |muscle cell differentiation| |cell fate commitment| |heart morphogenesis| |sensory organ morphogenesis| |regulation of animal organ morphogenesis| |positive regulation of growth| |aging| |striated muscle tissue development| |regulation of blood circulation| |embryonic organ morphogenesis| |muscle tissue development| |epithelial tube morphogenesis| |camera-type eye development| |RNA polymerase II regulatory region sequence-specific DNA binding| |regulation of developmental growth| |eye development| |visual system development| |sensory system development| |developmental growth| |growth| |blood vessel morphogenesis| |gland development| |sequence-specific DNA binding| |morphogenesis of an epithelium| |embryonic organ development| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |muscle structure development| |blood vessel development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |vasculature development| |cardiovascular system development| |heart development| |sensory organ development| |tissue morphogenesis| |embryonic morphogenesis| |regulation of system process| |tube morphogenesis| |regulation of growth| |tube development| |negative regulation of transcription by RNA polymerase II| |circulatory system development| |anatomical structure formation involved in morphogenesis| |positive regulation of cell population proliferation| |negative regulation of developmental process| |animal organ morphogenesis| |embryo development| |central nervous system development| |regulation of anatomical structure morphogenesis| |epithelium development| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp451|Atovaquone 15μM R08 exp451]]|-1.81| |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|-1.74| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-1.7| |[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|1.74| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|2.32| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7265 * **Expression level (log2 read counts)**: 0.84 {{:chemogenomics:nalm6 dist.png?nolink |}}